302 related articles for article (PubMed ID: 24909923)
1. Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin.
Thorp J; Palacios S; Symons J; Simon J; Barbour K
BJOG; 2014 Oct; 121(11):1328-31. PubMed ID: 24909923
[No Abstract] [Full Text] [Related]
2. Multiple measures of sexual function best identify therapy outcomes.
Wylie K
BJOG; 2014 Oct; 121(11):1332. PubMed ID: 25155449
[No Abstract] [Full Text] [Related]
3. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
Gao Z; Yang D; Yu L; Cui Y
J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
[TBL] [Abstract][Full Text] [Related]
6. Flibanserin and its discontents.
Aftab A; Chen C; McBride J
Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
[TBL] [Abstract][Full Text] [Related]
7. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
[TBL] [Abstract][Full Text] [Related]
8. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
Clayton AH; Dennerstein L; Pyke R; Sand M
Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
[TBL] [Abstract][Full Text] [Related]
9. Flibanserin for female sexual dysfunction.
Reviriego C
Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
[TBL] [Abstract][Full Text] [Related]
10. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
Simon JA; Thorp J; Millheiser L
J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
[No Abstract] [Full Text] [Related]
11. Flibanserin and Female Sexual Desire.
Fantasia HC
Nurs Womens Health; 2016; 20(3):309-14. PubMed ID: 27287358
[TBL] [Abstract][Full Text] [Related]
12. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
Kingsberg SA; Althof SE
J Sex Med; 2011 Dec; 8(12):3262-70. PubMed ID: 21883949
[TBL] [Abstract][Full Text] [Related]
13. [Flibanserin as pharmacological therapy of inhibited sexual desire in women].
Eldon AS; Giraldi A
Ugeskr Laeger; 2017 Feb; 179(7):. PubMed ID: 28397671
[TBL] [Abstract][Full Text] [Related]
14. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
Holt H; Tingen J
Am Fam Physician; 2016 May; 93(10):826-8. PubMed ID: 27175717
[No Abstract] [Full Text] [Related]
15. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
16. Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment.
Parish SJ; Hahn SR
Sex Med Rev; 2016 Apr; 4(2):103-120. PubMed ID: 27872021
[TBL] [Abstract][Full Text] [Related]
17. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Dhanuka I; Simon JA
Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
[TBL] [Abstract][Full Text] [Related]
18. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
[TBL] [Abstract][Full Text] [Related]
19. Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.
Simon JA; Kingsberg SA; Goldstein I; Kim NN; Hakim B; Millheiser L
Sex Med Rev; 2019 Oct; 7(4):575-586. PubMed ID: 31196764
[TBL] [Abstract][Full Text] [Related]
20. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
Fabre LF; Brown CS; Smith LC; Derogatis LR
J Sex Med; 2011 May; 8(5):1411-9. PubMed ID: 21324094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
